MedPath

Mobile phone intervention and Intermittent Preventive Treatment during pregnancy

Phase 3
Conditions
Malaria
Registration Number
PACTR202106905150440
Lead Sponsor
Centre Hospitalier Universitaire Yalgado Ouedraogo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
248
Inclusion Criteria

Residence in the study area and intention to stay in the area for the duration of the pregnancy and for delivery
Gestational age at the first antenatal visit = 20 weeks
Ability to comply with study procedures for the entire length of the study
Agreement to give signed informed consent

Exclusion Criteria

Residence outside the study area or planning to move out in the following 12 months from enrollment
Gestational age at the first antenatal visit > 20 weeks of pregnancy
Known history of allergy to sulfa drugs
Known history of severe renal, hepatic, psychiatric or neurological disease
Participating in other intervention studies
No access to a mobile phone in the family

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath